Specialty drugs are a central component of the evolving U.S. healthcare system. While definitions vary, a specialty drug is distinguished by a combination of factors, including its molecular structure, target condition and method of administration, among other special access requirements. These drugs include biologic and traditional medications alike, and often target chronic, rare and serious medical conditions, like cancer or multiple sclerosis (MS). The specialty drug market is at a tipping point: surging demand for complex therapies and rapid innovation are driving costs that strain traditional pricing, forcing stakeholders to rethink financing and access to balance affordability, equity and sustainable investment.
Read the full article: The Evolving Specialty Pharmacy Market: Trend in Demand, Distribution, Affordability and Policy //
Source: https://www.trillianthealth.com/hubfs/2024%20Website%20Redesign/Reports/2026%20Through%20Lines%20Specialty%20Pharmacy%20%7C%20Trilliant%20Health.pdf